MedTrace Logo

A Study on a Predictive Model for Efficacy and Prognosis of Pancreatic Carcinoma Based on Multimodal Data

NCT07561814 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1030

Last updated 2026-07-02

No results posted yet for this study

Summary

The goal of this observational study is to learn if combining information from CT scans, blood tests, and pathology reports can better predict how pancreatic cancer will progress.

The main questions it aims to answer are:

* Can combining these types of data more accurately estimate how long a person might survive?
* Can it better predict the risk of recurrence?

Participants will not have any extra tests or treatments. They will:

* Allow researchers to collect information from their existing medical records (such as surgery reports, imaging, and lab results)
* Receive a follow-up phone call for up to 3 years to share health updates（about every 3 months for the prospective cohort）.

Conditions

Sponsors & Collaborators

  • The First Affiliated Hospital of University of South China

    collaborator OTHER

  • First Affiliated Hospital Xi'an Jiaotong University

    collaborator OTHER

  • Shanghai Zhongshan Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-09
Primary Completion
2029-07-31
Completion
2029-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07561814 on ClinicalTrials.gov